國立虎尾科技大學 |

Magnetic resonance spectroscopy of degenerative brain diseases

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Magnetic resonance spectroscopy of degenerative brain diseases/ edited by Gulin Oz.
other author:	Oz, Gulin.
Published:	Cham :Springer International Publishing : : 2016.,
Description:	xv, 268 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Brain - Degeneration -
Online resource:	http://dx.doi.org/10.1007/978-3-319-33555-1
ISBN:	9783319335551

Magnetic resonance spectroscopy of degenerative brain diseases
Magnetic resonance spectroscopy of degenerative brain diseases[electronic resource] /edited by Gulin Oz. - Cham :Springer International Publishing :2016. - xv, 268 p. :ill. (some col.), digital ;24 cm. - Contemporary clinical neuroscience. - Contemporary clinical neuroscience..

Imaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.

The proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.

ISBN: 9783319335551

Standard No.: 10.1007/978-3-319-33555-1doiSubjects--Topical Terms:

1111130
Brain
--Degeneration

LC Class. No.: RC394.D35

Dewey Class. No.: 616.8047548

Magnetic resonance spectroscopy of degenerative brain diseases
LDR:02682nam a2200325 a 4500 001 865510
003 DE-He213
005 20161212162951.0
006 m d
007 cr nn 008maaau
008 170720s2016 gw s 0 eng d
020 $a 9783319335551 $q (electronic bk.)
020 $a 9783319335537 $q (paper)
024 7 $a 10.1007/978-3-319-33555-1 $2 doi
035 $a 978-3-319-33555-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC394.D35
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 616.8047548 $2 23
090 $a RC394.D35 $b M196 2016
245 0 0 $a Magnetic resonance spectroscopy of degenerative brain diseases $h [electronic resource] / $c edited by Gulin Oz.
260 $a Cham : $c 2016. $b Springer International Publishing : $b Imprint: Springer,
300 $a xv, 268 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Contemporary clinical neuroscience
505 0 $a Imaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.
520 $a The proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.
650 0 $a Brain $x Degeneration $x Magnetic resonance imaging. $3 1111130
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Neurosciences. $3 593561
650 2 4 $a Neurology. $3 593894
700 1 $a Oz, Gulin. $3 1111129
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Contemporary clinical neuroscience. $3 1064885
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-33555-1
950 $a Biomedical and Life Sciences (Springer-11642)